Halozyme Therapeutics (HALO) Misses Q3 EPS by 2c

Go back to Halozyme Therapeutics (HALO) Misses Q3 EPS by 2c
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.98 -0.47 (0.42%)
Previous Close $112.45    52 Week High $18.39 
Open $112.80    52 Week Low $6.96 
Day High $113.47    P/E N/A 
Day Low $111.05    EPS $-0.58 
Volume 1,933,253